Director, Cardiovascular Intensive Care Unit and Critical Care Echocardiography Vanderbilt University Medical Center Nashville, Tennessee
Disclosure(s): No relevant financial relationship(s) to disclose.
Disclosure(s):
Antonio Hernandez, MD, FCCM: No relevant financial relationship(s) to disclose.
The perioperative period is a crucial stage in the care of a patient with cancer. Perioperative interventions may affect long-term cancer outcomes. Surgical stress produces an environment that favours tumour growth and metastasis. Current evidence suggests that inhalational agents and opioid-based analgesia may have a deleterious effect on cancer outcomes; whilst propofol-TIVA, local anaesthetics, dexmedetomidine and regional anaesthetic techniques may be protective. Decisions on the best perioperative approach should be patient-specific and based on assessment of the relative risks and benefits of each intervention.
Presentations in this session: Immunomodulation in perioperative care - Antonio Hernandez, MD, FCCM What about sepsis? - Nuala Meyer, MD, MS Changing the immunology course post-ICU - Lyle Moldawer, PhD Immunomodulation in kids: more than growing up? - Jennifer Muszynski, MD, FCCM Personalised immunotherapy approaches in COVID-19 - Mark Hall, MD, FCCM A whistle stop tour of drugs! - Tuqa Alkhateeb, MS, PharmD
